Organigram Global Inc. (OGI) Financial Analysis & Valuation | Quarter Chart
Organigram Global Inc. (OGI)
OGIPrice: $1.52
Fair Value: 🔒
🔒score
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison... more
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived... more
Description
Shares
| Market Cap | $207.23M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | CA | CEO | James H. Yamanaka |
| IPO Date | 2019-05-21 | CAGR | — |
| Employees | 1,093 | Website | www.organigram.ca |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
OGI chart loading...
Fundamentals
Technicals
| Enterprise Value | $293.27M | P/E Ratio | 13.82 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 7.47 | P/B Ratio | 5.43 |
| P/CF Ratio | -263.21 | P/FCF Ratio | -80.27 |
| EPS | $0.11 | EPS Growth 1Y | -127.28% |
| EPS Growth 3Y | -254.93% | EPS Growth 5Y | -103.89% |
| Revenue Growth 1Y | 68.52% | Gross Margin | 0.04% |
| Operating Margin | -0.34% | Profit Margin | -0.1% |
| ROE | -0.07% | ROA | -0.04% |
| ROCE | -0.2% | Current Ratio | 2.26 |
| Quick Ratio | 1.28 | Cash Ratio | 0.66 |
| Debt/Equity | 0.03 | Interest Coverage | — |
| Altman Z Score | 0.42 | Piotroski Score | 3 |